人工智慧診斷市場:各零件,各診斷類型,各地區-規模,佔有率,展望,機會分析,2023年~2030年
市場調查報告書
商品編碼
1349867

人工智慧診斷市場:各零件,各診斷類型,各地區-規模,佔有率,展望,機會分析,2023年~2030年

Artificial Intelligence Diagnostics Market, By Component, By Diagnosis Type, By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄
根據預測,2022 年全球人工智慧 (AI) 診斷市場價值為 11.107 億美元,預計到 2030 年將達到 57.736 億美元,2023 年至 2030 年複合年增長率為 21.2%。

報告範圍 報告詳細資料
基準年 2022 2023 年市場規模 美國:15.029億美元
過去的資料 2018年至2021年 預測期間 2023-2030
預測 2023-2030 年複合年增長率: 21.20% 2030年價值預測 57.736億美元
人工智慧診斷市場-IMG1

人工智慧 (AI) 在醫療保健領域具有強大的潛力,有望快速、詳細地分析大量數據。在體外診斷 (IVD) 等領域,這可能會產生變革性的影響。因此,醫療保健領域對人工智慧技術的需求日益增加。

市場動態:

隨著人工智慧 (AI) 的發展和採用,醫療診斷實踐正在迅速改變。電腦處理的不斷改進使得基於人工智慧的系統能夠在各個專業領域提供準確、高效的診斷和治療管理計劃。由於運算能力、學習演算法、雲端儲存以及電子病歷資料集的可用性的進步,人工智慧可以在診斷和醫療保健領域發揮重要作用。人工智慧使放射科醫生和病理學家能夠在早期準確診斷醫療狀況,以便提供適當和有效的治療。

2017 年 12 月 PubMed 一篇關於人工智慧在放射學研究中應用的文章指出,下一個突破將不是來自創新的放射學設備,而是來自人工智慧的整合。這種整合可能會分階段進行。基於人工智慧的設備透過超音波、MRI、CT 和 PET 等影像技術收集數據。作為第一步,人工智慧已經對各種影像資料和結構進行自動分割,為放射科醫生提供了重要的分析價值並節省了時間。未來十年,基於人工智慧的放射學解決方案可能會用於在放射科醫生進行分析之前執行定量、分割和模式識別等常規任務,從而改善患者護理。

本調查的主要特徵

  • 本報告提供以2022年為基準年的預測期間(2023-2030 年)之全球人工智慧診斷市場的市場規模和復合年增長率(CAGR %)相關的詳區隔析。
  • 並闡明不同部門市場的潛在收入機會,說明該市場具有魅力的投資主張矩陣。
  • 同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
  • 並基於企業亮點,各類型投資組合、主要焦點、財務業績和市場策略等參數,介紹全球人工智慧診斷市場的主要參與者之企業簡介。
  • 藉由該報告提供的洞察,將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
  • 全球人工智慧診斷市場報告配合該行業的各種利益相關者,包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
  • 利益相關者可以透過全球人工智慧診斷市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

目錄

第1章 調查目的與前提條件

  • 調查目的
  • 前提條件
  • 簡稱

第2章 市場概況

  • 報告概要
    • 市場定義和範圍
  • 摘要整理
  • Coherent Opportunity Map(COM)

第3章 市場動態,法規,趨勢分析

  • 市場動態
    • 傳染病增加
    • 關於使用溫度計的擔憂
    • 對人工智慧 (AI) 診斷設備的高需求
  • 影響分析
  • 主要的焦點
  • 法規情勢
  • 產品銷售/核准
  • PEST分析
  • 波特分析
  • 合併·收購情勢

第4章 全球人工智慧診斷市場-冠狀病毒(COVID-19)大流行病的影響

  • COVID-19流行病學
  • 供給面和需求面的分析
  • 經濟影響

第5章 人工智慧診斷的全球市場:各零件,2023-2030年

  • 軟體
  • 硬體設備
  • 服務

第6章 人工智慧診斷的全球市場:各診斷類型,2020-2030年

  • 循環系統
  • 腫瘤學
  • 病理學
  • 放射線學
  • 神經學
  • 其他

第7章 人工智慧診斷的全球市場:各地區,2023-2030年

  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章 競爭情形

  • Vuno Inc.
  • CHC Healthcare Group
  • Aidoc
  • Imbio
  • Alivecor Inc.
  • Digital Diagnostics
  • Retina AI
  • Canon Medical Systems USA
  • Healthy IO
  • Milliman Inc.
  • GE Healthcare
  • Arterys
  • Alivecor Inc.
  • Riverain
  • Lucid Health
  • Qure.AI
  • Cardiologs

第9章 章節

  • 調查手法
  • 關於出版社
簡介目錄
Product Code: CMI6123

The global artificial intelligence (AI) diagnosis market was valued at US$ 1,110.7 Mn in 2022 and is forecast to reach a value of US$ 5,773.6 Mn by 2030 at a CAGR of 21.2% between 2023 and 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 1,502.9 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 21.20% 2030 Value Projection: US$ 5,773.6 Mn
Artificial Intelligence Diagnostics Market - IMG1

Artificial intelligence (AI) has powerful potential within healthcare, promising the ability to analyze vast amounts of data quickly and in detail. In a field such as in vitro diagnostics (IVD), which could have transformative implications. Thus, there is an increasing demand for artificial intelligence technology in healthcare sector.

Market Dynamics:

The practice of medical diagnostics is rapidly changing with the development and adoption of Artificial Intelligence (AI). Constant improvements in computer processing have enabled AI-based systems to provide accurate and efficient diagnosis & treatment management plans across various specializations. AI can play a big role in diagnosis and healthcare, with advancements in computing power, learning algorithms, cloud storage, and availability of datasets from electronic health records. It can enable radiologists and pathologists to accurately diagnosis conditions at an early stage to provide adequate & effective treatment.

In a PubMed article on applications of AI in radiology, in December 2017, it was studied that the next breakthrough would not be through an innovative radiology device but through the integration of AI. This integration is likely to take place in stages. AI-based devices are collecting data from imaging technologies, such as ultrasound, MRI, CT, and PET. In its first stage, AI is already performing automatic segmentation of various imaging data and structures to yield significant analytical value and help save the radiologist's time. Over the next decade, AI-based radiology solutions are likely to be used to perform routine tasks such as quantification, segmentation, and pattern recognition prior to the radiologist's analysis, thereby improving patient care delivery.

Key features of the study:

  • This report provides in-depth analysis of the global artificial intelligence (AI) diagnosis market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global artificial intelligence (AI) diagnosis market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Vuno Inc., CHC Healthcare Group, Aidoc, Imbio, Alivecor Inc., Digital Diagnostics, Retina AI, Canon Medical Systems USA, Healthy Io, Milliman Inc., GE Healthcare, Arterys, Alivecor Inc., Riverain, Lucid Health, Qure.AI, and Cardiologs, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global artificial intelligence (AI) diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence (AI) diagnosis market.

Detailed Segmentation:

  • Global Artificial Intelligence Diagnostics Market, By Component:
    • Software
    • Hardware
    • Services
  • Global Artificial Intelligence Diagnostics Market, By Diagnosis Type:
    • Cardiology
    • Oncology
    • Pathology
    • Radiology
    • Neurology
    • Others
  • Global Artificial Intelligence Diagnostics Market, By Geography:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles:
    • Vuno Inc.
    • CHC Healthcare Group
    • Aidoc
    • Imbio
    • Alivecor Inc.
    • Digital Diagnostics
    • Retina AI
    • Canon Medical Systems USA
    • Healthy IO
    • Milliman Inc.
    • GE Healthcare
    • Arterys
    • Alivecor Inc.
    • Riverain
    • Lucid Health
    • AI
    • Cardiologs

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Component
    • Market Snapshot, By Service Type
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising incidence of infectious diseases
    • Concerns about the use of thermometers
    • High demand for Artificial Intelligence (AI) diagnosis devices
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Artificial Intelligence (AI) Diagnosis Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Artificial Intelligence (AI) Diagnosis Market, By Component, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Hardware
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)

6. Global Artificial Intelligence (AI) Diagnosis Market, By Diagnosis Type, 2020-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Cardiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Pathology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Radiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)

7. Global Artificial Intelligence (AI) Diagnosis Market, By Geography, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2023-2030,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2023-2030,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2023-2030,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2023-2030,(US$ Mn)
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2023-2030,(US$ Mn)
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2023-2030,(US$ Mn)

8. Competitive Landscape

  • Vuno Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CHC Healthcare Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Aidoc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Imbio
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Alivecor Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Digital Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Retina AI
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Canon Medical Systems USA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Healthy IO
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Milliman Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Arterys
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Alivecor Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Riverain
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lucid Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Qure.AI
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cardiologs
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us